CDC director calls for agency’s overhaul, citing pandemic performance
By
Alicia Lasek
Aug 17, 2022
The Centers for Disease Control and Prevention will reorganize, with a new, action-oriented culture that better serves public health, Director Rochelle Walensky told her staff Wednesday.
Medicaid to cover all FDA-approved adult vaccines on Oct. 1, CMS reminds states
By
Alicia Lasek
Jun 28, 2023
The Centers for Medicare & Medicaid Services has released more information on mandatory state Medicaid and CHIP program coverage of vaccines recommended for adults.
Why long-term care advocates are holding their breath over likely Congress power shift
By
Joe Bush
Oct 20, 2022
The effort to alter long-term care workforce policies is waiting, along with the rest of the country, on pins and needles for Nov. 8 election results.
40 percent of adults with hearing loss do not inform their clinicians
By
Alicia Lasek
Mar 31, 2023
Adults who recognize that their hearing abilities have diminished often do not let their doctors or nurses know, a new study has found.
Medicare costs could soar with availability of new obesity drugs, experts say
By
Alicia Lasek
Mar 15, 2023
If efforts are successful to expand Medicare Part D to cover these drugs, premiums could soar, according to economists with Vanderbilt University and the University of Chicago.
White House announces big nursing home COVID-19 vaccination push and providers push back
By
Joe Bush
Nov 23, 2022
The Biden administration on Tuesday announced a six-week $475 million campaign to raise the COVID-19 vaccination rate among nursing home residents, and the sector’s leaders responded immediately with...
CDC says hospital data will keep healthcare providers on top of COVID-19
By
Alicia Lasek
May 11, 2023
As the public health emergency ends, new surveillance will help keep healthcare providers informed about disease trends and prepared for outbreaks, the agency says.
Common infections linked to reduced cognitive test scores for older adults
By
Alicia Lasek
Apr 23, 2023
Common infections, including with the herpes simplex virus, are associated with reduced performance on a test of global function, researchers from Johns Hopkins University report.
FDA: Evusheld may be less effective against latest COVID variants
By
Alicia Lasek
Oct 05, 2022
Evusheld, a preventive COVID-19 antibody for high-risk patients, may lose efficacy in the face of newly emerging variants, the FDA has informed clinicians.
GAO report finds ‘deficiencies’ in HHS’s handling of PHEs
May 15, 2023
Over a decades’ time, these issues have affected the nation’s response not only to COVID-19, but to past public health emergencies including the H1N1 influenza pandemic and extreme weather events...